Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma.

ABSTRACT:

Background

Transarterial (chemo-)embolization/lipiodolization (TAE/TAL) might be an attractive minimally invasive alternative to surgery in the treatment of symptomatic hepatic haemangioma. This review assesses the efficacy and safety of TAE/TAL as primary treatment for symptomatic hepatic haemangioma.

Methods

A systematic search of the literature was performed by two reviewers following the PRISMA guidelines. Cohort studies and case reports were identified; outcomes of cohort studies were reported. The primary efficacy outcome was tumour size before and after TAE/TAL. Improvement of symptoms and quality of life (QoL) were secondary outcomes; the primary safety outcome was complications. The Downs and Black statement was used for quality assessment.

Results

Eighteen c

SUBMITTER: Furumaya A 

PROVIDER: S-EPMC6503075 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature